CYTOMX THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

19 11 2024 08:56:48 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

18 11 2024 08:58:03 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

15 11 2024 08:54:07 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

11 11 2024 09:14:07 提供 NetDania Notify

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

07 11 2024 15:10:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

06 11 2024 13:45:07 提供 NetDania Notify

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

31 10 2024 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

29 10 2024 14:57:21 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

28 10 2024 10:30:57 提供 NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

25 10 2024 10:27:19 提供 NetDania Notify

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors

09 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming September Investor Conferences

04 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

08 8 2024 15:10:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

01 8 2024 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

18 6 2024 07:00:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

17 6 2024 15:15:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

22 5 2024 15:05:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

16 5 2024 15:15:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

08 5 2024 15:10:00 提供 Nasdaq GlobeNewswire

CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)

08 5 2024 15:10:00 提供 Nasdaq GlobeNewswire